Stock listing

OTC:MHTX Manhattan Scientifics, Inc. Stock

Follow Manhattan Scientifics, Inc. into a list and get an email when it puts out news.

Manhattan Scientifics, Inc. logo
Ticker
OTC:MHTX
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

All Manhattan Scientifics, Inc. news

Manhattan Scientifics, Inc. on 6ix

News releases
42 in all · newest Jun 29, 2023 · oldest 2014

Events

QuarterResults
Quarter to Sep 30, 2024Nov 27, 2024
Q2 2024Aug 19, 2024 · Before open
Q1 2024May 15, 2024 · After close
Q4 2023Mar 27, 2024 · After close
Q3 2023Nov 20, 2023 · Before open
Q2 2023Aug 21, 2023 · After close
Q1 2023May 22, 2023 · After close
Q4 2022Mar 1, 2023
Q3 2022Nov 14, 2022
Q2 2022Aug 31, 2022
All 16 quarters
QuarterResults
Q1 2022May 17, 2022
Q4 2021Mar 2, 2022
Q3 2021Dec 1, 2021
Q2 2021Sep 1, 2021
Q1 2021May 18, 2021
Q4 2020Mar 3, 2021

Open Events

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue050.0K50.0K50.0K97.0K0142.0K150.0K64.0K642.0K
Cost of revenue1.00K3.00K2.00K725.0K07.00K189.0K43.0K3.99M3.92M
Gross profit-1.00K50.0K50.0K50.0K97.0K-7.00K-47.0K107.0K64.0K642.0K
Research and development10.0K11.0K10.0K11.0K8.00K52.0K175.0K3.33M2.94M1.86M
Selling, general and administrative693.0K718.0K727.0K714.0K1.11M1.39M2.06M3.20M3.38M2.26M
Operating income-703.0K-679.0K-687.0K-675.0K-1.02M-1.45M-2.28M-6.38M-6.25M-3.47M
Depreciation and amortization1.00K3.00K2.00K2.00K2.00K622.0K857.0K995.0K793.0K202.0K
EBITDA-702.0K-676.0K-685.0K-673.0K-1.02M-826.0K-1.42M-5.39M-5.46M-3.27M
Interest expense021.0K26.0K25.0K5.00K00488.0K675.0K330.0K
Income before tax-1.17M-2.73M-3.64M4.31M-1.22M-8.33M1.55M-6.11M8.01M-3.81M
Income tax-1.17M2.03M26.0K25.0K5.00K-6.89M1.00K488.0K675.0K0
Net income-1.17M-2.73M-3.64M4.31M-1.22M-8.33M1.55M-6.11M8.01M-3.81M
Earnings per share, basic-0.00-0.00-0.010.01-0.00-0.020.00-0.010.01-0.01

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents67.0K175.0K232.0K353.0K261.0K87.0K269.0K1.07M5.36M2.53M
Short-term investments5.88M0000
Receivables300.0K300.0K300.0K44.0K
Inventory-300.0K-300.0K-300.0K0000
Current assets69.0K189.0K547.0K665.0K574.0K98.0K278.0K1.11M5.36M2.53M
Property, plant and equipment4.00K6.00K4.00K6.00K8.00K165.0K291.0K144.0K
Goodwill0000
Total assets316.0K1.03M3.45M6.85M2.23M2.66M10.8M7.63M12.9M3.63M
Accounts payable133.0K119.0K102.0K159.0K234.0K221.0K209.0K472.0K829.0K426.0K
Current liabilities2.12M1.67M1.36M1.01M2.09M1.75M1.63M1.71M1.29M1.79M
Long-term debt104.0K78.0K002.14M1.93M1.62M
Total debt60.0K110.0K130.0K104.0K78.0K2.41M2.38M2.96M
Total liabilities2.12M2.73M2.42M2.17M3.23M2.81M2.69M4.91M4.28M4.46M
Shareholders' equity-1.80M-1.70M1.03M4.67M-1.00M-150.0K8.16M2.72M8.59M-832.0K
Shares outstanding559.3M559.3M559.3M593.1M549.4M533.8M533.8M534.7M593.4M485.6M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-190.0K-349.0K-421.0K-388.0K-316.0K-682.0K-791.0K-4.56M3.42M-2.54M
Capital spending000-4.00K-4.00K-4.00K-8.00K-13.0K-255.0K-36.0K
Free cash flow-190.0K-349.0K-421.0K-392.0K-316.0K-682.0K-799.0K-4.57M3.16M-2.57M
Cash from investing102.0K332.0K300.0K480.0K340.0K500.0K-8.00K-13.0K-255.0K-36.0K
Cash from financing-20.0K-40.0K024.0K150.0K150.0K150.0K275.0K-324.0K4.52M
Dividends paid0000
Share buybacks000-330.0K3.52M
Change in cash-108.0K-57.0K-121.0K92.0K174.0K-182.0K-799.0K-4.30M2.84M1.95M

Open Financials

Cap table

Built by 6ix from Manhattan Scientifics, Inc.’s releases

Common shares
559,281,064
Fully diluted
559,281,064

Fully diluted

LineShares
Common shares559,281,064

Share count over time

CountShares
Nov 22, 2026559,281,064

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Strategic Investment Solutions, Inc.2,500<0.01%Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Marvin Maslow
Other companies: Dror Ortho-Design Inc. (Director · Feb 6, 2006 – Dec 12, 2006 · Past)
Chief Executive Officer · Aug 17, 2007 – Aug 17, 2007 · Past
Chris TheoharisTreasurer, Director · Oct 11, 2007 – Jun 30, 2016 · Past
Emmanuel TsoupanariasCEO and Chairman of the Board, Director · Jun 30, 2014 – Jun 30, 2014 · Past
Leonard FriedmanSecretary, Director · Jun 30, 2014 – Jun 30, 2016 · Past
Photios Frank GeorgiouDirector · Oct 11, 2007 – Jun 30, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Manhattan Scientifics, Inc.